logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8361796 B1

PDFFull Text
Expired
Date of Patent:
Jan. 29, 2013

Filed:

Mar. 10, 2009

Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications

Applicants:

Philippe Menasche, Paris, FR;

Michel Puceat, Champcueil, FR;

Jérôme Larghero, Boulogne-Billancourt, FR;

Guillaume Blin, Paris, FR;

David Nury, Corbeil, FR;

Sonia Stefanovic, Draveil, FR;

Inventors:

Philippe Menasche, Paris, FR;

Michel Puceat, Champcueil, FR;

Jérôme Larghero, Boulogne-Billancourt, FR;

Guillaume Blin, Paris, FR;

David Nury, Corbeil, FR;

Sonia Stefanovic, Draveil, FR;

Assignees:

Assistance Publique—Hopitaux de Paris, Paris, FR;

Institut National de la Sante et de la Recherche Medicale (Inserm), Paris, FR;

Universite Paris Descartes, Paris, FR;

Universite Paris Diderot Paris 7, Paris, FR;

Attorney:

Buchanan Ingersoll & Rooney P.C.

Primary Examiner:

Marcia S Noble

Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is directed to a method for the in vitro preparation of cardiovascular progenitors cells from mammalian embryonic stem cells (ES cells) or mammalian embryonic-like state cells, preferably from primate, wherein said method comprises the use of the CD15 (SSEAI) marker as a positive cardiovascular progenitors differentiation marker. The present invention also claimed the use of a receptor tyrosine kinase inhibitor, particularly the SU5402 or SU11248 in association with the BMP2 for improving the efficiency of the desired differentiation. The present invention is also directed to the use of platelet lysate as foetal animal serum substitute in a culture medium intended to the proliferation or propagation of primate ES cells maintaining their pluripotency feature. Derived compositions or kits in relation with the claimed methods or product obtainable by the claimed methods form also part of the present invention.

Find Patent Forward Citations

Quick Actions:

Menasche, Philippe. (2013). Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications (U.S. Patent No. 8361796). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8361796

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…